ExeGi Pharma Announces Clearance of Investigational New Drug (IND) Application for EXE- 46 a Live Biotherapeutic Biologic Drug ...Middle East

ROCKVILLE, Md., Jan. 26, 2023 /PRNewswire/ -- ExeGi Pharma LLC, a leader in the development of live biotherapeutic drugs and probiotics, announced today that the FDA has cleared its Investigational New Drug (IND) application for its biologic drug candidate, EXE-346. This clearance allows...

Hence then, the article about exegi pharma announces clearance of investigational new drug ind application for exe 46 a live biotherapeutic biologic drug was published today ( Friday 27/01/2023 - 04:25 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ExeGi Pharma Announces Clearance of Investigational New Drug (IND) Application for EXE- 46 a Live Biotherapeutic Biologic Drug )

Also on site :

• Gaza plan phase two: US to discuss Hamas disarmament, Israeli withdrawal
• ‘I hope they show humanity’: Greenlanders fear Trump’s desire for minerals
• Amazon Has 'Super Warm' and ‘Soft' Mini Sheepskin Boots on Sale for $50, and They're 'Worth Every Penny'